Company News
Venus Remedies Receives First Global Plerixafor Approval
Venus Remedies received its first global Marketing Authorization from Saudi FDA for oncology drug Plerixafor 24mg/1.2ml.
The approval advances the company's strategic shift into complex, higher-value
